We have previously reported that antiMullerian hormone (AMH), also known as Mfillerianinhibiting substance, the testicular glycoprotein involved in regression of the Mullerian ducts of the mnale fetus, induces the formation of seminiferous cord-like structures in fetal ovaries exposed to it in organ culture. We have now investigated the effect of bovine AMH, purified to homogeneity, on ovarian endocrine differentiation. Ovine fetal ovaries exposed to AMH release testosterone instead of estradiol, an endocrine sex reversal due to suppression of aromatase activity. AMH dramatically decreases the conversion rate of testosterone to estradiol and also decreases total aromatase activity, as measured by the tritiated water technique. AMH acts by decreasing aromatase biosynthesis rather than by blocking enzyme activity, as suggested by the relatively long period of AMH exposure required to produce an effect. In the rabbit fetal ovary, aromatase activity is AMH-responsive during the whole gestational period. The basal steroidogenic activity of rat fetal ovaries is extremely low but can be markedly increased by cAMP. AMH completely blocks the effect of cAMP. Taken together, our results suggest that AMH plays a pivotal role in both morphological and endocrine gonadal sex differentiation. New Zealand rabbits were sacrificed between day 16 and 28 of gestation. Prior to day 20, fetal sex was determined by a sex chromatin test performed on a fragment of the amniotic membrane (12); in older fetuses, sex was easily identified under the dissecting microscope. Wistar rat fetuses were used at 15 days postcoitum; sex was recognized macroscopically. Fetal age was counted from the day of mating, which was considered day 0.
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According to the Jost hypothesis (1), which has now gained general acceptance, sex differentiation is a sequential, ordered, and relatively simple process. Maleness is imposed at an early stage on genital primordia that would otherwise become female. The initial genetic "masculinizing trigger," which overrides the constitutive program towards femaleness, resides in a 230-kilobase region of the human Y chromosome (2) . The encoded protein, ZFY, is believed to act indirectly by regulating transcription of other gene(s) not necessarily located on the Y chromosome.
Anti-Mullerian hormone (AMH), also known under the name of Mullerian-inhibiting substance or factor, is a testicular glycoprotein responsible for the regression of Mullerian ducts in male fetuses. The hormone has been purified (3), cloned (4, 5) , and mapped to the tip of the short arm of chromosome 19 (6) . We have shown that AMH induces gonadal morphological masculinization through differentiation of seminiferous cord-like structures in fetal rat ovaries explanted in organ culture (7) .
Mammalian endocrine sex differentiation is characterized by production of testosterone by the testis and of estradiol by the ovary (8, 9) . To determine if AMH also affects the pattern of fetal gonadal hormone secretion, we have investigated the effect of bovine AMH upon early steroidogenesis of ovine fetal ovaries. We show that AMH induces endocrine sex reversal by suppressing ovarian aromatase activity, an effect also demonstrable with rabbit and rat fetal ovaries.
MATERIALS AND METHODS
Animals. Female sheep of the Prdalpes-Romanov breed were superovulated with 100 international units of pregnant mare serum gonadotropin (Chronogest PMSG, Intervet, Angers, France). Fetuses were removed by cesarean section between day 29 and 47 postcoitum and brought to the laboratory within 5 hr. Placentas corresponding to multiple pregnancies were checked for vascular anastomoses between fetuses, to exclude the possibility of gonadal changes due to freemartinism. Fetal sex was determined by direct chromosome analysis of "=20 metaphase figures of hepatic hematopoietic cells, according to a modification of the technique of Luciani et al. (10) . The Y chromosome is easily identified as the smallest metacentric element (11) .
New Zealand rabbits were sacrificed between day 16 and 28 of gestation. Prior to day 20, fetal sex was determined by a sex chromatin test performed on a fragment of the amniotic membrane (12) ; in older fetuses, sex was easily identified under the dissecting microscope. Wistar rat fetuses were used at 15 days postcoitum; sex was recognized macroscopically. Fetal age was counted from the day of mating, which was considered day 0.
Reagents. Bovine AMH was purified by immunochromatography on a monoclonal antibody-conjugated matrix (3) and quantified by radioimmunoassay (13) . Other unlabeled reagents were purchased from Sigma; [7-3H] ,4g/ml) sterilized by filtration through 0.22 GV membranes (Millipore). This batch of AMH produces complete regression of fetal rat Mullerian ducts at a concentration of 1.5 gg/ml (results not shown). Culture medium was renewed after 2 or 3 days.
Measurement of Gonadal Steroid Secretion. Testosterone and estradiol were assayed in culture medium of sheep fetal gonads by specific radioimmunoassay after ethyl ether extraction followed by chromatographic purification on celite columns, as described (15, 16) .
Assay of Aromatase Activity. Cytochrome P-450 aromatase activity was measured at the end of the culture period. Fetal gonads were incubated in CMRL 1066 at 370C in a Dubnoff incubator under a 95% 02/5% CO2 atmosphere for 3.5 or 5.5 hr, according to species, in the presence of appropriate steroid precursors. Aromatization oftestosterone to estradiol was assayed by using 0.7 ,uM [7-3H] testosterone. Steroids were extracted from culture medium by ethyl acetate; estradiol was isolated by chromatography on a celite column and purified by silica gel TLC, acetylation, and rechromatography according to a modification of the technique of Milewich et al. (17) .
Total aromatase activity was measured by the tritiated water technique (18) Thompson and Siiteri (19) ; 65% of the label was released as tritiated water (results not shown). The data were corrected accordingly. Placental Aromatase Activity. Aromatase activity was measured in microsomes prepared from human placentas (19) . An amount corresponding to 0.025 mg of protein was preincubated 30 min in the presence or absence of AMH at 3 ,ug/ml. NADPH (0.025 mg) and 0.7 ,uM [1f3-3H]androstenedione were then added, and the aromatase activity was measured after 30 min.
Protein Determination. Proteins were measured by the Bradford technique (20) after tissue solubilization by 0.5 M NaOH for 20 hr at 37°C and neutralization by 1 M HCl.
Histology. In each set of experiments involving more than 4 days in culture, one experimental and one control gonad were fixed in Bouin's fluid, dehydrated, embedded in paraffin, serially sectioned at 5 ,um, and stained with Ehrlich's hematoxylin and eosin.
RESULTS
Effect of AMH on Gonadal Steroid Production. Ovaries of 29-day-old sheep fetuses were explanted in organ culture for 9 days. Estradiol and testosterone were assayed in culture medium, which was renewed at 3-day intervals. Steroid production, which was barely detectable during the first 3 days in culture, rose progressively thereafter. Ovaries in control medium secreted estradiol and low amounts of testosterone; fetal testes cultured under the same conditions did the opposite. As shown in Fig. 1 , AMH-treated ovaries no longer released estradiol and secreted testosterone instead, at levels comparable to those seen in control testes.
Effect of AMH on Aromatase Activity. Ovine fetal ovaries.
After AMH treatment in organ culture, cytochrome P-450 aromatase enzymatic activity was assayed in ovine fetal ovaries by two independent techniques. Fig. 2A shows the conversion of a tritiated testosterone precursor to estradiol by 29-day-old fetal ovaries after 9 days in culture. In contrast Effect of AMH on steroid production by ovine fetal gonads explanted at day 29 (1 or 2 per culture dish). Results are expressed as means ± SEM of eight independent assays. Steroids were assayed in culture medium, renewed at 3-day intervals, by specific radioimmunoassay. After 3 days in culture, fetal ovaries produce increasing amounts of estradiol, whereas fetal testes secrete testosterone. AMH treatment sex-reverses the steroidogenic pattern of fetal ovaries.
to those cultured in control medium, AMH-treated ovaries are unable to convert testosterone to estradiol. Estradiol formation is also very low in control testes. Assay of total aromatase activity by the tritiated water technique, shown in Fig. 2B , confirms the inhibitory effect of AMH upon the development of ovarian aromatase in 29-day-old ovaries. Basal aromatase activity peaks in 44-day-old ovaries and remains relatively high 5 days later; at all ages, a 3-day treatment with AMH reduces enzymatic activity down to the level observed in control testes.
Rabbit Ratfetal ovaries. Aromatase activity of control 15-day-old rat fetal ovaries is relatively low but rises dramatically after stimulation by Bt2cAMP (Fig. 4) 
DISCUSSION
At the time of gonadal sex differentiation, ovarian development is characterized by the initiation of estradiol production. The level and timing of ovarian estrogen secretion are subject to species variation. In sheep fetuses, high amounts of estradiol are produced by young ovaries, but estrogen production is not maintained beyond midgestation (9) . In this species, the effect of AMH upon steroidogenesis can be directly investigated. AMH sex-reverses the steroid production of 29-day-old fetal ovaries; it causes them to secrete testosterone instead of estradiol (Fig. 1 ). This is due to defective aromatization of testosterone as shown by the failure of AMH-treated ovaries to convert this steroid to estradiol ( Fig. 2A) . Total aromatase activity is also suppressed by AMH (Fig. 2B) .
Rabbit fetal ovaries secrete relatively low amounts of estradiol, but they maintain their production up to the time of birth (8) . The inhibitory effect of AMH upon aromatase activity of rabbit ovaries, particularly striking at the beginning of gestation, is still significant 4 days before birth (Fig.  3) . The steroidogenic activity of rat fetal ovaries is extremely low up to birth, but aromatase activity can be stimulated by Bt2cAMP from day 13 or 14 onwards (21). At 15 days postcoitum, AMH treatment reduces the enzymatic activity of Bt2cAMP-stimulated rat fetal ovaries below the level observed in controls (Fig. 4) .
A relatively long period of exposure is needed for AMH to develop a maximal effect. This suggests that AMH operates at the level of enzyme biosynthesis rather than upon enzymatic activity, as also indicated by the failure of AMH to inhibit placental microsomal aromatase.
As previously demonstrated (7), rat fetal ovaries exposed to AMH undergo germ cell loss and differentiation of epithelial cells with some characteristics of Sertoli cells, which aggregate in seminiferous cord-like structures. These ovarian changes closely resemble those observed by Jost and his coworkers in freemartins (22) (23) (24) (25) , bovine females united in utero to male twins by placental anastomoses, which allows dissemination of testicular AMH in the female circulation (26) . In the present study, related changes were observed in ovine fetal ovaries explanted at day 29 however, less conspicuous than in the rat; this could be due to the fact that ovine ovaries were explanted at a much earlier stage of development and differentiate at a much slower pace (27) . Altered steroidogenesis, characterized by abnormal testosterone production and the absence of normally occurring estrogen, has been demonstrated in the young bovine freemartin fetal ovary (28) . We believe that AMH, which mimics the freemartin condition in both its morphogenetic and endocrine aspects, is in all likelihood the testicular factor responsible for ovarian masculinization in the female twin. Does AMH play a physiological role in normal testicular differentiation? The fact that inherited defects in AMH biosynthesis, which lead to persistence of Mullerian derivatives in males (29), do not affect testicular differentiation does not support this hypothesis. However, the degree of implication of AMH in testicular differentiation could be variable, and other factors could compensate for the lack of AMH in some species.
In conclusion, we would like to suggest that AMH is one of the testis-determining factor-regulated Sertoli cell signals implicated in the cascade of events that lead to the differentiation of the testis. For instance, as suggested by others (8, 9) , locally synthesized estrogen could function to initiate ovarian growth and differentiation. We suggest that this estrogen synthesis is constitutive and must be inhibited by AMH to allow the fetal gonad to differentiate as a testis.
Up to now, estimation of anti-Mullerian biological activity has relied on a semiquantitative bioassay that uses rat fetal Mullerian ducts as target organs (30) . Inhibition of ovarian aromatase activity, which can be easily and accurately measured with the tritiated water technique, should be useful in developing a quantitative assay of AMH bioactivity.
